title: [Antiplatelet therapy in atherosclerosis of various localizations: acute and stable States].
abstract: We present in this review current data on specificities of efficacy and safety of antiplatelet therapy in patients with atherosclerosis of various localizations. Reduced priority of aspirin monotherapy in several clinical situations is shown. Controversial issues of the use of dual antiplatelet therapy including its application in patients with acute coronary syndrome are discussed. Novel groups of antiplatelet agents as well as individual new drugs are also presented.
authors.forename: N A
authors.initials: NA
authors.lastname: Koziolova
mesh_terms: D054058:Acute Coronary Syndrome / Q000209:etiology / Q000517:prevention & control; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D020379:Risk Adjustment; D013988:Ticlopidine / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin